Shimoji M - Search Results

1

Oncogene swap as a novel mechanism of acquired resistance to epidermal growth factor receptor-tyrosine kinase inhibitor in lung cancer.

Mizuuchi H, Suda K, Murakami I, Sakai K, Sato K, Kobayashi Y, Shimoji M, Chiba M, Sesumi Y, Tomizawa K, Takemoto T, Sekido Y, Nishio K, Mitsudomi T. Mizuuchi H, et al. Among authors: shimoji m. Cancer Sci. 2016 Apr;107(4):461-8. doi: 10.1111/cas.12905. Epub 2016 Mar 28. Cancer Sci. 2016. PMID: 26845230 Free PMC article.

2

Small non-mucinous bronchioloalveolar carcinoma with anaplastic lymphoma kinase immunoreactivity: a novel ALK fusion gene?

Yamamoto M, Takeuchi K, Shimoji M, Maniwa T, Isaka M, Nakagawa K, Ohde Y, Kondo H, Nakajima T. Yamamoto M, et al. Among authors: shimoji m. Cancer Sci. 2012 Feb;103(2):390-2. doi: 10.1111/j.1349-7006.2011.02136.x. Cancer Sci. 2012. PMID: 22296236 Free article.

3

Recent evidence, advances, and current practices in surgical treatment of lung cancer.

Suda K, Sato K, Mizuuchi H, Kobayashi Y, Shimoji M, Tomizawa K, Takemoto T, Iwasaki T, Sakaguchi M, Mitsudomi T. Suda K, et al. Among authors: shimoji m. Respir Investig. 2014 Nov;52(6):322-9. doi: 10.1016/j.resinv.2014.06.003. Epub 2014 Jul 11. Respir Investig. 2014. PMID: 25453375 Review.

4

EGFR Exon 18 Mutations in Lung Cancer: Molecular Predictors of Augmented Sensitivity to Afatinib or Neratinib as Compared with First- or Third-Generation TKIs.

Kobayashi Y, Togashi Y, Yatabe Y, Mizuuchi H, Jangchul P, Kondo C, Shimoji M, Sato K, Suda K, Tomizawa K, Takemoto T, Hida T, Nishio K, Mitsudomi T. Kobayashi Y, et al. Among authors: shimoji m. Clin Cancer Res. 2015 Dec 1;21(23):5305-13. doi: 10.1158/1078-0432.CCR-15-1046. Epub 2015 Jul 23. Clin Cancer Res. 2015. PMID: 26206867

5

Heterogeneity of EGFR Aberrations and Correlation with Histological Structures: Analyses of Therapy-Naive Isogenic Lung Cancer Lesions with EGFR Mutation.

Suda K, Murakami I, Yu H, Ellison K, Shimoji M, Genova C, Rivard CJ, Mitsudomi T, Hirsch FR. Suda K, et al. Among authors: shimoji m. J Thorac Oncol. 2016 Oct;11(10):1711-7. doi: 10.1016/j.jtho.2016.05.017. Epub 2016 May 31. J Thorac Oncol. 2016. PMID: 27257133 Free PMC article.

6

Clinical and pathologic features of lung cancer expressing programmed cell death ligand 1 (PD-L1).

Shimoji M, Shimizu S, Sato K, Suda K, Kobayashi Y, Tomizawa K, Takemoto T, Mitsudomi T. Shimoji M, et al. Lung Cancer. 2016 Aug;98:69-75. doi: 10.1016/j.lungcan.2016.04.021. Epub 2016 May 25. Lung Cancer. 2016. PMID: 27393509

7

Characterization of EGFR T790M, L792F, and C797S Mutations as Mechanisms of Acquired Resistance to Afatinib in Lung Cancer.

Kobayashi Y, Azuma K, Nagai H, Kim YH, Togashi Y, Sesumi Y, Chiba M, Shimoji M, Sato K, Tomizawa K, Takemoto T, Nishio K, Mitsudomi T. Kobayashi Y, et al. Among authors: shimoji m. Mol Cancer Ther. 2017 Feb;16(2):357-364. doi: 10.1158/1535-7163.MCT-16-0407. Epub 2016 Dec 2. Mol Cancer Ther. 2017. PMID: 27913578

8

Prognostic impact of pleural lavage cytology in patients with primary lung cancer.

Tomizawa K, Nishino M, Sesumi Y, Kobayashi Y, Sato K, Chiba M, Shimoji M, Suda K, Shimizu S, Sato T, Takemoto T, Mitsudomi T. Tomizawa K, et al. Among authors: shimoji m. Lung Cancer. 2016 Dec;102:60-64. doi: 10.1016/j.lungcan.2016.10.009. Epub 2016 Oct 24. Lung Cancer. 2016. PMID: 27987590

9

Effect of dasatinib on EMT-mediated-mechanism of resistance against EGFR inhibitors in lung cancer cells.

Sesumi Y, Suda K, Mizuuchi H, Kobayashi Y, Sato K, Chiba M, Shimoji M, Tomizawa K, Takemoto T, Mitsudomi T. Sesumi Y, et al. Among authors: shimoji m. Lung Cancer. 2017 Feb;104:85-90. doi: 10.1016/j.lungcan.2016.12.012. Epub 2016 Dec 21. Lung Cancer. 2017. PMID: 28213007

10

Determination of poor prognostic immune features of tumour microenvironment in non-smoking patients with lung adenocarcinoma.

Kinoshita T, Kudo-Saito C, Muramatsu R, Fujita T, Saito M, Nagumo H, Sakurai T, Noji S, Takahata E, Yaguchi T, Tsukamoto N, Hayashi Y, Kaseda K, Kamiyama I, Ohtsuka T, Tomizawa K, Shimoji M, Mitsudomi T, Asamura H, Kawakami Y. Kinoshita T, et al. Among authors: shimoji m. Eur J Cancer. 2017 Nov;86:15-27. doi: 10.1016/j.ejca.2017.08.026. Epub 2017 Sep 23. Eur J Cancer. 2017. PMID: 28950145

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

142 results

Search Page

Filters